TD Cowen Cuts UiPath (NYSE:PATH) Price Target to $13.00

UiPath (NYSE:PATHFree Report) had its target price reduced by TD Cowen from $16.00 to $13.00 in a report issued on Thursday morning,Benzinga reports. They currently have a hold rating on the stock.

Other analysts have also issued reports about the stock. Wells Fargo & Company reduced their price objective on shares of UiPath from $14.00 to $13.00 and set an “equal weight” rating on the stock in a report on Thursday. Evercore increased their target price on shares of UiPath from $15.00 to $17.00 and gave the stock an “in-line” rating in a research note on Thursday, December 4th. Canaccord Genuity Group dropped their price target on shares of UiPath from $19.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday. Zacks Research downgraded shares of UiPath from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 6th. Finally, Mizuho decreased their price objective on shares of UiPath from $15.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of “Hold” and an average target price of $14.27.

Get Our Latest Research Report on PATH

UiPath Stock Performance

PATH opened at $11.58 on Thursday. The stock has a market capitalization of $6.19 billion, a PE ratio of 22.27, a P/E/G ratio of 1.58 and a beta of 1.09. UiPath has a one year low of $9.38 and a one year high of $19.84. The business’s 50 day moving average price is $12.97 and its 200 day moving average price is $14.00.

UiPath (NYSE:PATHGet Free Report) last posted its earnings results on Wednesday, March 11th. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.05. UiPath had a return on equity of 5.95% and a net margin of 17.53%.The company had revenue of $481.11 million during the quarter, compared to analysts’ expectations of $464.81 million. During the same quarter last year, the firm earned $0.26 earnings per share. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. As a group, equities research analysts forecast that UiPath will post -0.17 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $15.73, for a total transaction of $707,850.00. Following the sale, the chief executive officer directly owned 28,343,585 shares of the company’s stock, valued at $445,844,592.05. This represents a 0.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Ashim Gupta sold 67,468 shares of the stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the sale, the chief financial officer owned 557,028 shares in the company, valued at approximately $8,968,150.80. This trade represents a 10.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 787,468 shares of company stock valued at $12,862,285 in the last 90 days. Company insiders own 23.19% of the company’s stock.

Institutional Trading of UiPath

Several hedge funds have recently modified their holdings of PATH. Royal Bank of Canada grew its stake in UiPath by 8.4% during the 1st quarter. Royal Bank of Canada now owns 140,774 shares of the company’s stock worth $1,450,000 after purchasing an additional 10,872 shares in the last quarter. Woodline Partners LP raised its position in UiPath by 69.6% in the 1st quarter. Woodline Partners LP now owns 22,566 shares of the company’s stock valued at $232,000 after purchasing an additional 9,257 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of UiPath by 5.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,477,730 shares of the company’s stock valued at $15,221,000 after buying an additional 75,737 shares during the period. Sivia Capital Partners LLC purchased a new position in shares of UiPath in the 2nd quarter valued at about $169,000. Finally, Campbell & CO Investment Adviser LLC acquired a new position in shares of UiPath during the second quarter worth about $843,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting UiPath

Here are the key news stories impacting UiPath this week:

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Featured Stories

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.